Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines-Reference-Cited by-同舟云学术

Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines

Published:2013-06 Issue:6 Volume:37 Page:675-680
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Davidoff Amy J.,Weiss Sheila R.,Baer Maria R.,Ke Xuehua,Hendrick Franklin,Zeidan Amer,Gore Steven D.

Funder

Novartis

Celgene

GlaxoSmithKline

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference37 articles.

1. Management of RBC-transfusion dependence;Melchert;Hematol Am Soc Hematol Educ Program,2007

2. The WHO classification of MDS does make a difference;Howe;Blood,2004

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Drugs@FDA drug information database. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails (accessed 05.09.11).

5. Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients;Hellström-Lindberg;Blood,1998

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geographic disparities in cardiovascular mortality among patients with myelodysplastic syndromes: A population-based analysis.;Cancer Epidemiology;2022-10

2. Management of the Older Patient with Myelodysplastic Syndrome;Drugs & Aging;2021-08-03

3. The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study;Indian Journal of Hematology and Blood Transfusion;2021-06-26

4. Clinical effectiveness of DNA methyltransferase inhibitors and lenalidomide in older patients with refractory anemia with ring sideroblasts: a population-based study in the United States;Leukemia & Lymphoma;2021-04-24

5. Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options;Cancer Management and Research;2021-01